Cofoe Medical Technology 可孚医疗
25 significant filings since 30 May 2026: 2 on share pledge, 13 on buyback and 3 on dividend, and 4 other kinds. The latest, on 23 Sep 2026: 关于控股股东部分股份质押的公告.
自 30 May 2026 起有 25 份重大公告：share pledge 2 份、buyback 13 份、dividend 3 份，另有 4 类。最新一份（23 Sep 2026）：关于控股股东部分股份质押的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 10 May 2026 | 太平洋 | 谭紫媚,李啸岩 | Outperform 增持 | ▲ | Buy 买入 |
| 27 Oct 2022 | 国金证券 | 袁维 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 太平洋 | 谭紫媚 | Buy 买入 | 1 Sep 2026 | 2 | — |
| 信达证券 | 唐爱金 | Buy 买入 | 6 May 2026 | 2 | — |
| 开源证券 | 余汝意,陈峻,石启正 | Buy 买入 | 12 Mar 2026 | 1 | — |
| 中邮证券 | 盛丽华,陈峻 | Buy 买入 | 20 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 6 reports. 每行为该券商近十二个月的最新研报；6 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。